Skip to main content
. 2023 Nov 15;9(11):e22413. doi: 10.1016/j.heliyon.2023.e22413

Table 2.

Diseases with treatments associated with VMAT2 pathway.

Huntington's disease chorea Tetrabenazine, deutetrabenazine [89].
Depression Fluoxetine; Bupropion [68,69]
Parkinson's Pramipexole, Apomorphine [86,87]
Bipolar disorder Lithium [66].
Arrhythmia Amiodarone [67].
psychostimulants Cocaine, methamphetamine, Phencyclidine [[73], [74], [75], [76], [77]]
psychosis Clozapine [85]
Tardive Dyskinesia Valbenazine, Deutetrabenazine [[23], [24], [25]].